<![CDATA[Pharmaceutical Executive Daily: FDA Shelves CNPV Program]]>
In today’s Pharmaceutical Executive Daily, the FDA reportedly shelves its Commissioner’s National Priority Voucher program for expedited drug reviews, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site to produce next-generation …